VITAL
Phase 3 Completed
913 enrolled 16 charts
Pharmaco-economic Study of a Second Line Treatment in Advanced Non Small Cell Lung Cancer
Phase 3 Completed
150 enrolled
AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer (EGIA-002)
Phase 2 Completed
35 enrolled 17 charts
LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib
Phase 3 Completed
231 enrolled 33 charts
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors
Phase 1 Completed
40 enrolled
Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer
Phase 2 Completed
29 enrolled 11 charts
Ultimate
Phase 3 Completed
166 enrolled
Bevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Phase 2 Completed
13 enrolled 9 charts
Docetaxel With or Without PI-88 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase 2 Completed
98 enrolled
Amrubicin (AMR) Trial in Patients With Non-small Cell Lung Cancer
Phase 3 Completed
202 enrolled
Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)
Phase 2 Completed
69 enrolled
Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer
Phase 2 Completed
75 enrolled 7 charts
REFRACT
Phase 2 Completed
59 enrolled
NVALT10
Phase 2 Completed
195 enrolled
Avastin/Docetaxel/Carboplatin in Non-Small Cell Lung Cancer
Phase 2 Completed
43 enrolled 10 charts
Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Phase 2 Completed
58 enrolled
0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer
Phase 2 Completed
109 enrolled 6 charts
A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy
Phase 3 Completed
1,253 enrolled 18 charts
Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer
Phase 2 Completed
40 enrolled
Combination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB NSCLC
Phase 2 Completed
46 enrolled
Clinical Study of Chinese Medicine Plus Chemotherapy Maintenance in Advanced Non Small Cell Lung Cancer
Phase 3 Completed
71 enrolled
Bevacizumab and Docetaxel in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Phase 2 Completed
11 enrolled 8 charts
Docetaxel and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
Phase 1/2 Completed
81 enrolled 14 charts
Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)
Phase 2 Completed
42 enrolled 7 charts
Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer
Phase 2 Completed
162 enrolled 9 charts
ZPACT
Phase 3 Completed
250 enrolled
Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
Phase 1 Completed
45 enrolled
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
Phase 2 Completed
121 enrolled
Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer
Phase 2 Completed
32 enrolled
Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)
Phase 3 Completed
67 enrolled
ZODIAC
Phase 3 Completed
1,690 enrolled 15 charts
Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)in Combination With Docetaxel for the Treatment of Non-Small Cell Lung Cancer
Phase 1/2 Completed
47 enrolled
Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Phase 2 Completed
80 enrolled
Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Phase 2 Completed
106 enrolled
Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer
Phase 2 Completed
48 enrolled
Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase 2 Completed
160 enrolled
Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
33 enrolled
Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer
Phase NA Completed
25 enrolled 6 charts
Pemetrexed or Docetaxel With or Without Erlotinib in Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase 2 Completed
46 enrolled 12 charts
Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer
Phase 1/2 Completed
Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC)
Phase 2 Completed
27 enrolled 8 charts
Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy
Phase NA Completed
6 enrolled 6 charts
A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients
Phase 2 Completed
29 enrolled 10 charts
A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
Phase 2 Completed
226 enrolled
TFINE
Phase 3 Completed
375 enrolled
Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer
Phase 4 Completed
133 enrolled 8 charts
Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer
Phase 3 Completed
600 enrolled
S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors
Phase 2 Completed
46 enrolled 9 charts
Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)
Completed
100 enrolled
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
35 enrolled